MYBL2 mRNA expression as a potential biomarker of therapeutic response to genotoxic treatments in myelodysplastic syndrome

Research output: Contribution to journalEditorialpeer-review

Standard

MYBL2 mRNA expression as a potential biomarker of therapeutic response to genotoxic treatments in myelodysplastic syndrome. / Bayley, Rachel; Blakemore, Daniel; García, Paloma.

In: OncoTarget, Vol. 9, No. 101, 01.12.2018, p. 37460-37461.

Research output: Contribution to journalEditorialpeer-review

Harvard

APA

Vancouver

Author

Bibtex

@article{26eb47e1463d4c4db1acbdcbeb47f16b,
title = "MYBL2 mRNA expression as a potential biomarker of therapeutic response to genotoxic treatments in myelodysplastic syndrome",
keywords = "Aging, Blood disorders, DNA repair, MDS, Stem cells",
author = "Rachel Bayley and Daniel Blakemore and Paloma Garc{\'i}a",
year = "2018",
month = dec,
day = "1",
language = "English",
volume = "9",
pages = "37460--37461",
journal = "OncoTarget",
issn = "1949-2553",
publisher = "Impact Journals",
number = "101",

}

RIS

TY - JOUR

T1 - MYBL2 mRNA expression as a potential biomarker of therapeutic response to genotoxic treatments in myelodysplastic syndrome

AU - Bayley, Rachel

AU - Blakemore, Daniel

AU - García, Paloma

PY - 2018/12/1

Y1 - 2018/12/1

KW - Aging

KW - Blood disorders

KW - DNA repair

KW - MDS

KW - Stem cells

UR - http://www.scopus.com/inward/record.url?scp=85059171956&partnerID=8YFLogxK

M3 - Editorial

AN - SCOPUS:85059171956

VL - 9

SP - 37460

EP - 37461

JO - OncoTarget

JF - OncoTarget

SN - 1949-2553

IS - 101

ER -